|
|
|
|
|
|
INTERMEDIATES |
NO. |
PRODUCT
NAME |
|
01 |
1,3-Benzenediacetonitrile |
120511-74-2 |
02 |
3,5-Bis(bromomethyl)toluene |
19294-04-3 |
03 |
3,5-Bis(2-cyanoprop-2-yl)toluene |
120511-72-0 |
04 |
6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-1,2,3,4-dihydroisoquinolineHydrochloride |
-- |
05 |
N',N'-(4,10-dioxa-3,11-dioxo-tridecanylene)-1,13-bis(1,2,3,4-tetrahydroisoquinoline)-bioxalate |
-- |
06 |
ethyl 4-(1-methyl-5-nitro-1H-benzo[d]imidazol-2-yl)butanoate |
3543-72-4 |
07 |
1-Methyl-5-amino-1H-benzimidazole-2-butanoic acid ethyl ester |
3543-73-5 |
08 |
5-[Bis(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester |
3543-74-6 |
09 |
(R)-BoroLeu-(+)-Pinanediol-CF3COOH |
179324-87-9 |
10 |
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropionamide |
90356-78-8 |
11 |
1,2,3- triacetoxy -5-deoxy-D-ribose |
62211-93-2 |
12 |
2',3'-Di-O-acetyl-5’-deoxy-5-fluorocytidine |
161599-46-8 |
13 |
Tetrahydropapaverine hydrochloride |
6429-04-5 |
14 |
R-CONDENSATE OXALIC ACID |
96687-52-4 |
15 |
R-TATRAHYDROPAPAVERINE HCL |
54417-53-7 |
16 |
2,3,5-Tri-O-benzoyl-beta-D-ribose |
67525-66-0 |
17 |
beta-D-Ribofuranose 1-acetate 2,3,5-tribenzoate |
6974-32-9 |
18 |
1,3,5-Tri-O-benzoyl-D-ribofuranose |
22224-41-5 |
19 |
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-D-ribofuranose |
97614-43-2 |
20 |
(4R,6S)-5,6-Dihydro-4-hydroxy-6-methylthieno[2,3-b]thiopyran-7,7-dioxide |
147128-77-6 |
Next page
* The products under valid patents will not be offered to the
countries covered by the patents. |
|
|
|